How to Help with Hair Loss
Start with topical minoxidil 5% twice daily for men or 2% twice daily for women as first-line treatment for androgenetic alopecia, which is the most common cause of hair loss. 1, 2
Determine the Type of Hair Loss
The pattern of hair loss guides diagnosis and treatment:
- Diffuse central scalp thinning with preserved frontal hairline indicates androgenetic alopecia (most common cause) 1
- Discrete circular patches with exclamation mark hairs (short broken hairs at margins) are pathognomonic for alopecia areata 1
- Sudden loss of "handfuls" of hair suggests telogen effluvium, often following stress or illness 3
- Scalp inflammation or scaling indicates tinea capitis or scarring alopecia requiring different management 1
Laboratory Testing Strategy
Do not order extensive testing when the diagnosis is clinically evident. 1 Most cases of androgenetic alopecia and alopecia areata do not require laboratory work.
Order targeted tests only when indicated:
- Check TSH and free T4 if thyroid disease is suspected (common cause of hair loss) 1
- Check serum ferritin if iron deficiency suspected; optimal level ≥60 ng/mL is needed for hair growth 1
- Check vitamin D and zinc levels if nutritional deficiency suspected 3
- Check total testosterone, free testosterone, and SHBG only if signs of androgen excess present (acne, hirsutism, irregular periods) 1
- Fungal culture only if tinea capitis suspected based on scalp inflammation 1
- Skin biopsy reserved for uncertain diagnosis or suspected scarring alopecia 1
Treatment by Diagnosis
Androgenetic Alopecia (Pattern Hair Loss)
For men: Initiate combination therapy with oral finasteride 1 mg daily plus topical minoxidil 5% solution twice daily for optimal results. 1 This combination halts progression and stimulates regrowth better than either agent alone.
For women: Topical minoxidil 2% solution twice daily is first-line treatment, which arrests progression rather than stimulates regrowth. 1 Women should not use minoxidil 5% as it works no better than 2% and may cause unwanted facial hair growth. 2
Critical application details from FDA labeling:
- Apply twice daily with 4 hours between application and hair washing 2
- Each 1 mL dose should be applied directly to the scalp in the hair loss area 2
- Treatment must be continuous; stopping results in resumption of hair loss 1
- Results may take 2-4 months to appear 2
- Initial increased shedding for up to 2 weeks is expected and indicates the medication is working 2
Adjunctive option: Platelet-rich plasma (PRP) injections with 3-5 sessions at 1-month intervals, then maintenance every 6 months, show increased hair density in clinical trials. 1
Alopecia Areata (Patchy Hair Loss)
For limited patchy disease (<50% scalp involvement): Watchful waiting with reassurance is legitimate first-line management, as 34-50% recover within one year without treatment. 1, 3
If treatment desired: Intralesional triamcinolone acetonide 5-10 mg/mL injected into affected patches. 1, 3
For extensive disease (>50% scalp involvement): Contact immunotherapy is the best-documented treatment, though response rate is less than 50% and requires multiple hospital visits over months. 1 Wigs provide immediate cosmetic benefit. 1
Counsel patients that:
- No treatment alters the long-term course of alopecia areata 1
- Regrowth cannot be expected within 3 months of any individual patch development 1
- Some treatments can induce temporary regrowth only 1
Telogen Effluvium (Diffuse Shedding)
Spontaneous remission occurs in up to 80% of cases with short duration (<1 year). 3 Treatment focuses on identifying and removing the trigger (stress, illness, medications, nutritional deficiency).
- Supplement vitamin D, zinc, and folate if deficiencies identified 3
- Reassure patients that recovery typically occurs once the underlying cause resolves 3
Tinea Capitis (Fungal Infection)
Requires systemic oral antifungal therapy as topical treatments are ineffective. 4 Confirm diagnosis with fungal culture before initiating treatment. 1
Treatments to Avoid
Do not use the following for alopecia areata due to lack of efficacy or serious side effects:
- Potent topical corticosteroids (lack convincing evidence) 1
- Systemic corticosteroids or PUVA (inadequate efficacy evidence with potentially serious side effects) 1
- Oral zinc or isoprinosine (ineffective in controlled trials) 1
Common Pitfalls
- Ordering extensive autoimmune panels in straightforward alopecia areata cases is unnecessary and wasteful 1
- Failing to consider trichotillomania where broken hairs remain firmly anchored, distinguishing it from alopecia areata 1
- Expecting rapid results from minoxidil; patients need 2-4 months minimum before assessing efficacy 2
- Discontinuing treatment prematurely when initial shedding occurs in the first 2 weeks of minoxidil use 2
- Not addressing psychological impact of hair loss, which commonly causes anxiety, depression, and reduced quality of life 4